Education-first compound profiles. Plain English explanations, mechanism breakdowns, and COA documentation โ all in one place.
๐ก FDA PCAC briefing + new compound profiles โ regulatory updates, new compound profiles, COA alerts.
โ ๏ธ FDA PCAC: -- days leftNo spam. Unsubscribe anytime. 7 peptides under review โ see what's at stake โ
A triple-receptor agonist studied for metabolic research. Acts on GLP-1, GIP, and glucagon receptors simultaneously โ one of the most potent metabolic research peptides available.
Read profile โ Weight ManagementA dual GLP-1/GIP receptor agonist at the forefront of metabolic research. Used as a key reference compound in receptor pharmacology studies worldwide.
Read profile โ Weight ManagementA long-acting GLP-1 receptor agonist with one of the most extensive research bodies of any modern peptide. Studied across metabolic, cardiovascular, and neurological research contexts.
Read profile โ Weight ManagementA modified C-terminal fragment of human growth hormone studied for selective activity on fat cell metabolism. Isolates the lipid-targeting properties of HGH without its growth-promoting effects.
Read profile โ Weight ManagementA triple monoamine reuptake inhibitor originally studied for neurological conditions, now examined in metabolic research for its central nervous system approach to appetite signaling.
Read profile โ Weight ManagementA dual GLP-1/glucagon receptor agonist studied for simultaneous appetite suppression and hepatic fat oxidation. Phase 3 SYNCHRONIZE-1: 16.6% weight loss. FDA Breakthrough Therapy for MASH.
Read profile โ Weight ManagementNovo Nordisk's fixed-dose combination of cagrilintide 2.4mg + semaglutide 2.4mg. REDEFINE 1: 22.7% mean body weight loss at 68 weeks. Dual GLP-1/amylin receptor agonist targeting two complementary appetite pathways.
Read profile โ Anti-Aging & LongevityA synthetic tetrapeptide developed from pineal gland research, studied for telomerase activation and circadian regulation. One of the most extensively researched compounds in Russian gerontology.
Read profile โ Anti-Aging & LongevityThe first peptide discovered to be encoded within mitochondrial DNA. Studied for neuroprotection, insulin sensitivity, and cellular stress defense โ with circulating levels that decline with age.
Read profile โ Anti-Aging & LongevityA Szeto-Schiller peptide that concentrates ~1,000-fold in the inner mitochondrial membrane, binding cardiolipin to protect mitochondrial architecture. One of the most clinically advanced mitochondria-targeted peptides studied.
Read profile โ Anti-Aging & LongevityA mitochondrial-derived peptide linked to cellular energy regulation and metabolic homeostasis. Unique among peptides โ encoded in mitochondrial DNA, not nuclear DNA.
Read profile โ Anti-Aging & LongevityA coenzyme essential to cellular energy production, DNA repair, and sirtuin activation. One of the most studied molecules in aging and longevity research.
Read profile โ Cognitive & NeuroA synthetic heptapeptide derived from tuftsin, studied for its dual influence on the GABAergic system and BDNF expression. Developed by the Russian Academy of Sciences.
Read profile โ Cognitive & NeuroA synthetic ACTH fragment studied for neuroprotection and BDNF upregulation. One of the few peptides to achieve pharmaceutical approval (in Russia) for clinical stroke recovery.
Read profile โ Cognitive & NeuroAn angiotensin IV analog developed at Washington State University, studied for its potent promotion of synaptogenesis via the HGF/MET signaling pathway.
Read profile โ Cognitive & NeuroA short peptide derived from spadin that blocks TREK-1 potassium channels in the brain. Studied for neuroplasticity effects and mood-related research with rapid-onset laboratory profiles.
Read profile โ Cognitive & NeuroAn enhanced Semax derivative (N-Acetyl Semax Amidate) studied for cognitive enhancement, BDNF upregulation, neuroprotection, and neuroplasticity. A more stable, potent version of the ACTH 4-10 fragment analog.
Read profile โ Immune & AntimicrobialA naturally produced thymic peptide with one of the most extensive clinical research bodies in the immune support category. Approved as Zadaxin in over 35 countries.
Read profile โ Immune & AntimicrobialA naturally occurring antimicrobial cathelicidin peptide with dual antimicrobial and immune signaling activity. Your body produces it in neutrophils, macrophages, and even skin cells.
Read profile โ Immune & AntimicrobialA thymic polypeptide complex developed in the Soviet Union, studied for immune restoration in aging research contexts. Examined in some of the longest-running peptide follow-up studies published.
Read profile โ Skin & CosmeticA naturally occurring copper-binding tripeptide studied for collagen synthesis, gene expression modulation, and tissue remodeling. One of the most-researched compounds in skin science.
Read profile โ Skin & CosmeticA cyclic analog of ฮฑ-MSH that activates multiple melanocortin receptors (MC1R, MC3R, MC4R). A key research tool in melanocortin system pharmacology for over 30 years.
Read profile โ Skin & CosmeticA melanocortin receptor agonist (Bremelanotide) that became the first FDA-approved drug acting via central nervous system melanocortin pathways, approved in 2019 as Vyleesi.
Read profile โ Recovery & HealingA synthetic 15-amino-acid pentadecapeptide derived from a gastric protective protein. Reclassified to FDA Category 1 in April 2026 โ restoring research access after 2+ years as Category 2. One of the most extensively studied recovery peptides with 300+ preclinical papers.
Read profile โ Recovery & HealingA synthetic fragment of one of the most abundant proteins in mammalian cells, studied for its central role in actin regulation, cell migration, and tissue repair signaling โ including cardiac repair models.
Read profile โ Recovery & HealingA tripeptide derived from the C-terminal end of alpha-MSH, studied for potent anti-inflammatory signaling via NF-ฮบB inhibition in gut and skin tissue โ without the melanocortin receptor side effects of full ฮฑ-MSH.
Read profile โ Recovery & HealingThe 15-amino-acid body protection compound class from which BPC-157 derives โ studied for gastrointestinal cytoprotection and systemic healing with unusual stability in gastric acid environments.
Read profile โ Growth HormoneA GHRH analog with DAC (Drug Affinity Complex) modification that extends its half-life from minutes to days โ studied for sustained pituitary GH stimulation and downstream IGF-1 elevation.
Read profile โ Growth HormoneThe most selective GHRP in widespread research use โ stimulates natural-pattern GH pulses via the ghrelin receptor without cortisol, prolactin, or appetite side effects that complicate older GHRPs.
Read profile โ Growth HormoneA stabilized GHRH analog with FDA approval (Egrifta) for visceral fat reduction in HIV lipodystrophy โ one of the few peptides in this library with Phase III clinical trial data and regulatory approval history.
Read profile โ Growth HormoneThe original synthetic GHRH analog โ a 29-amino-acid fragment with FDA approval history as Geref. The most extensively studied GHRH analog in medicine, now a reference standard for the class.
Read profile โ Growth HormoneThe pioneer hexapeptide that launched the GHRP class โ and indirectly led to the discovery of ghrelin. Produces potent GH release via ghrelin receptors, with appetite stimulation as a studied off-target effect.
Read profile โ Growth HormoneA second-generation hexapeptide GHRP with superior potency to GHRP-6 via D-amino acid modifications. Received pharmaceutical approval in Japan as Pralmorelin for GH deficiency diagnostics.
Read profile โ Growth HormoneA non-peptide, orally active ghrelin mimetic โ the only GH secretagogue in this library that survives oral administration. Studied in multiple Merck clinical trials for GH deficiency and sarcopenia.
Read profile โ 🧬 Blend StackThe most commonly studied peptide healing combination. BPC-157's localized tissue repair and angiogenesis meets TB-500's systemic actin regulation and cell migration โ complementary mechanisms studied together for synergistic repair biology.
Read stack profile โ 🧬 Blend StackThe premier dual-pathway GH secretagogue combination. CJC-1295 activates GHRH receptors while Ipamorelin activates ghrelin receptors (GHSR-1a) โ two independent pathways studied for synergistic pituitary growth hormone stimulation.
Read stack profile โ 🧬 Blend StackBoth Russian-developed, both studied for BDNF upregulation โ but through entirely different CNS pathways. Selank's GABAergic modulation and Semax's ACTH-fragment neuroprotection are studied together for complementary cognitive research effects.
Read stack profile โ 🧬 Blend StackBroad-spectrum gene expression modulation meets targeted tissue repair signaling. GHK-Cu's influence on 4,000+ human genes combined with BPC-157's angiogenesis and growth hormone receptor upregulation in tissue remodeling research.
Read stack profile โ 🧬 Blend StackAdaptive immunity meets innate immunity. Thymosin Alpha-1's thymic T-cell regulation and LL-37's antimicrobial cathelicidin activity studied together โ the only human cathelicidin paired with the most clinically-studied immune peptide.
Read stack profile โ 🧬 Blend StackTriple anti-aging peptide stack combining GHK-Cu's gene expression modulation across 4,000+ human genes with BPC-157's tissue repair and TB-500's systemic cell migration โ studied for collagen remodeling and regenerative synergy.
Read stack profile โ 🧬 Blend StackFour-compound anti-aging stack adding KPV's NF-ฮบB-mediated inflammation resolution to the Glow triad. Covers gene expression, tissue repair, actin dynamics, and immune modulation across complementary signaling pathways.
Read stack profile โRegulatory updates, industry developments, and research breakthroughs in the peptide research landscape.
Every compound in this library is profiled strictly for research and educational purposes. No compound on this site is intended for human or veterinary use, clinical or diagnostic applications, or therapeutic use of any kind.
Analyze interactions between any combination of peptides, AAS, SERMs, GLP-1s, and blends. 41 compounds, 25+ named rules, 6 risk dimensions. Free, no login required.